☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Alkermes
Alkermes Reports Results of Lybalvi in P-IIIb (ENLIGHTEN-Early) Study for the Treatment of Schizophrenia or Bipolar I Disorder
February 9, 2022
Insights+: Key Deals of J.P. Morgan Healthcare Conference 2020
February 7, 2020
PharmaShots Weekly Snapshot (January 27-31, 2020)
February 3, 2020
Insights+: The US FDA New Drug Approvals in September and October 2019
November 15, 2019
PharmaShots Weekly Snapshot (October 28 - November 01, 2019)
November 4, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
